scholarly journals Prognostic impact of primary tumor SUVmax on preoperative 18F-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography in endometrial cancer and uterine carcinosarcoma

2016 ◽  
Vol 5 (4) ◽  
pp. 467-474 ◽  
Author(s):  
Tamaki Yahata ◽  
Shigetaka Yagi ◽  
Yasushi Mabuchi ◽  
Yuko Tanizaki ◽  
Aya Kobayashi ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Endometrial Cancer ◽  
Primary Tumor ◽  
Emission Tomography ◽  
Prognostic Impact ◽  
Uterine Carcinosarcoma ◽  
Positron Emission

The Role of Positron Emission Tomography/Computed Tomography in Planning Radiotherapy in Endometrial Cancer

2015 ◽  
Vol 25 (4) ◽  
pp. 645-649 ◽  
Author(s):  
Bryony Simcock ◽  
Kailash Narayan ◽  
Elizabeth Drummond ◽  
David Bernshaw ◽  
Elizabeth Wells ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Endometrial Cancer ◽  
Adjuvant Radiotherapy ◽  
Emission Tomography ◽  
Optimal Method ◽  
Positron Emission ◽  
Pet Ct ◽  
High Risk Disease

ObjectiveThe optimal method of assessing disease distribution in endometrial cancer is widely debated. Knowledge of disease distribution assists in planning adjuvant radiotherapy; in this study we used positron emission tomography/computed tomography (PET/CT) to assess disease distribution before radiotherapy.MethodsSeventy-three consecutive patients referred to the Peter MacCallum Cancer Centre for adjuvant radiotherapy for endometrial cancer, with either high-risk disease after a hysterectomy or recurrent disease, had a PET/CT before treatment. The findings on PET/CT and clinical course were recorded.ResultsPET/CT found additional disease in 35% of postoperative patients, changing planned treatment in 31%. In the group with known recurrence, additional disease was found in 72%, changing management in 36%.ConclusionsPET/CT is a valuable tool for planning radiotherapy in endometrial cancer.

Sign in / Sign up

Export Citation Format

Share Document